Evidence map›Paper›PMID 40787076›Full record

ArticleCrystal growth & design2025

First Crystal Structure of an Aspartame Cocrystal.

Nazanin Fereidouni, Marwah Aljohani, Andrea Erxleben

Abstract read
In one paragraph

Article in Crystal growth & design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nazanin FereidouniSchool of Biological and Chemical Sciences, University of Galway, Galway H91TK33, Ireland.
Marwah AljohaniDepartment of Chemistry, College of Science, Imam Abdulrahman Bin Faisal University, P.O. Box 76971, Dammam 31441, Saudi Arabia.
Andrea ErxlebenSchool of Biological and Chemical Sciences, University of Galway, Galway H91TK33, Ireland.ORCID https://orcid.org/0000-0002-7309-8972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspartame crystallizes as very long, thin needles. The crystallization behavior of extreme needle formers not only causes problems in industrial processing and handling but is also of interest in fundamental research. Cocrystallization is a popular approach to expand the solid-state landscape of a compound and often leads to improved physicochemical properties such as stability, dissolution behavior, particle size, and morphology. No crystal structure of an aspartame cocrystal has been reported in the literature up to now. In this work, a comprehensive screening study for aspartame cocrystals was performed. Cocrystals with fumaric acid and 4-hydroxybenzoic acid were detected by powder X-ray diffraction analysis. Growing X-ray suitable cocrystals, however, proved extremely difficult, as both cocrystals, like aspartame, crystallized as very fine needles. Nevertheless, in the case of 4-hydroxybenzoic acid, crystals of sufficient quality for single-crystal X-ray analysis could be grown, and the first crystal structure of an aspartame cocrystal is reported. In the cocrystal aspartame·4-hydroxybenzoic acid dihydrate (

Identifiers

PMID40787076
PMCPMC12333019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.